State of New Jersey Common Pension Fund D Sells 10,141 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

State of New Jersey Common Pension Fund D decreased its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 25.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 29,701 shares of the company’s stock after selling 10,141 shares during the quarter. State of New Jersey Common Pension Fund D owned approximately 0.06% of Prestige Consumer Healthcare worth $2,045,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. grew its holdings in Prestige Consumer Healthcare by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 5,756,138 shares of the company’s stock worth $352,391,000 after acquiring an additional 63,375 shares in the last quarter. Victory Capital Management Inc. boosted its stake in shares of Prestige Consumer Healthcare by 9.0% during the second quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company’s stock valued at $142,827,000 after purchasing an additional 171,357 shares in the last quarter. Allspring Global Investments Holdings LLC increased its holdings in Prestige Consumer Healthcare by 26.0% during the second quarter. Allspring Global Investments Holdings LLC now owns 1,320,125 shares of the company’s stock valued at $90,891,000 after buying an additional 272,773 shares during the period. Congress Asset Management Co. MA raised its stake in Prestige Consumer Healthcare by 12.5% in the first quarter. Congress Asset Management Co. MA now owns 764,013 shares of the company’s stock worth $55,437,000 after buying an additional 84,757 shares in the last quarter. Finally, The Manufacturers Life Insurance Company lifted its holdings in Prestige Consumer Healthcare by 5.3% during the fourth quarter. The Manufacturers Life Insurance Company now owns 605,376 shares of the company’s stock worth $37,061,000 after buying an additional 30,288 shares during the period. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, DA Davidson lifted their price target on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $98.75.

Prestige Consumer Healthcare Price Performance

Shares of PBH opened at $73.01 on Friday. The company has a 50 day moving average of $71.22 and a two-hundred day moving average of $69.67. The company has a market cap of $3.62 billion, a price-to-earnings ratio of 17.51, a price-to-earnings-growth ratio of 2.08 and a beta of 0.48. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65. Prestige Consumer Healthcare Inc. has a twelve month low of $56.34 and a twelve month high of $75.80.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.04. The company had revenue of $267.10 million for the quarter, compared to analyst estimates of $260.54 million. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The firm’s quarterly revenue was down 4.4% compared to the same quarter last year. During the same period in the prior year, the company posted $1.06 EPS. As a group, analysts predict that Prestige Consumer Healthcare Inc. will post 4.42 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.